A novel expression system based on coinfection of cells with two recombinant vaccinia viruses has been developed. One recombinant vaccinia virus contained the bacteriophage T7 RNA polymerase gene under control of a vaccinia virus promoter. The second recombinant vaccinia virus contained a target gene of choice flanked by bacteriophage T7 promoter and termination sequences. Maximum expression of the target gene occurred when cells were infected with 10 PFU of each recombinant virus. Although T7 RNA polymerase synthesis began shortly after infection, the target gene was not expressed until late times and was largely inhibited when DNA replication was blocked. Target gene transcripts were analyzed by agarose gel electrophoresis and had the predicted size. With this system, Escherichia coli (-galactosidase, hepatitis B virus surface antigen, and human immunodeficiency virus envelope proteins were made. In each case, the level of synthesis was greater than had previously been obtained with the more conventional recombinant vaccinia virus expression system. Molecular cloning vectors have been developed that allow expression of heterologous genes in procaryotic and eucaryotic cells. Genetic elements carried by these vectors typically confer drug resistance, ability to replicate autonomously, and regulatory controlling elements juxtaposed to the target gene of interest. While this approach has been extensively used in bacterial and mammalian cell expression systems, certain features of one system may be advantageous over another. Bacteria are easy to use and high expression is often attainable, but synthesis of native eucaryotic proteins is frequently not achieved. Mammalian cells can faithfully express eucaryotic proteins, but usually at relatively low levels. An expression system that used procaryotic transcriptional elements in mammalian cells might have important advantages since the catalytic activity, induciblity, and promoter specificity are well characterized.
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For these reasons, a chimeric expression system that used favorable transcriptional components from bacteria in a eucaryotic milieu may offer a highly specific and efficient method for the synthesis of ecuaryotic proteins.
A eucaryotic transient-expression system based on a recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase in the cytoplasm of infected cells was recently described (5) . Plasmids containing the target genes flanked by T7 promoter and termination sequences were introduced into infected cells by transfection procedures. The efficiency of the vaccinia virus-T7 transient system relative to that of more conventional mammalian transient expression systems was attributed to the high catalytic activity of T7 RNA polymerase and stringent T7 promoter specificity. Since it is possible to infect tissue culture cells synchronously with vaccinia virus, the absolute level of expression was probably limited by transfection of the target gene. It would seem that the efficiency of the system would be enhanced if vaccinia virus were used to deliver the target gene as well as the T7 RNA polymerase. Increased copy number of the target gene template might also result from a 10,000 to 20,000 amplification of the virus genome during replication. (8) . RNA was transferred to nitrocellulose and hybridized to 32P-labeled probes as described by Thomas (21) . Probes were prepared and nick translated by the method described by Maniatis et may reflect a requirement for replication and concomitant genomic amplification of the recombinant virus for expression of either the T7 RNA polymerase or the T7 promotertarget gene template. To test this, cells were coinfected with vTF7-3 and vTF7LZ-1 in the presence or absence of cytosine arabinoside (araC), an inhibitor of vaccinia virus DNA replication (3). In cells infected with the vaccinia virus-T7 hybrids, araC inhibited expression of p-gal by 80 to 90% throughout infection (Table 4 ). In contrast, with the single vaccinia virus recombinant vTFLZ, araC had no effect on P,-gal expression early during infection but inhibited expression by about 50% at later times. The latter results are consistent with the early/late P7.5 promoter used for construction of vTFLZ.
We measured the levels of T7 RNA polymerase to determine whether inhibition of P-gal expression by araC was due to the kinetics of polymerase synthesis or to inhibition of template virus replication. Cells were infected with recombinant virus vTF7-3 in the presence and absence of araC, and lysates were prepared at various times after infection and assayed in vitro for T7 RNA polymerase with a DNA template containing a T7 promoter (Fig. 3) . In the absence of inhibitor, T7 RNA polymerase activity was detected within 3 h and continued to increase for more than 12 h. AraC had little or no effect on T7 RNA polymerase activity during the early phase of infection but inhibited activity by approximately 50% after 12 h, consistent with the use of the 7.5-kDa promoter. Thus, the severe reduction in p-gal in coinfected cells in the presence of araC was probably not due to the absence of T7 RNA polymerase. Northern blot analysis of lacZ transcripts. The late expression of 3-gal could be due to either an early block in transcription or translation of the mRNAs. To distinguish between these possibilities, P-gal mRNA was analyzed.
CV-1 cells were coinfected with vTF7-3 and vTF7LZ-1, and at various times after infection, bulk cytoplasmic RNA was isolated, separated by agarose gel electrophoresis, blotted to nitrocellulose, and probed with 32P-labeled pTF7LZ-1 (Fig.  4) . A 3.3-kb lacZ transcript was only observed from 6 h after infection. The size of the lacZ transcript corresponded to that predicted (33-nucleotide 410 leader, 3.2-kb lacZ coding sequence, and 110-nucleotide TX sequence), suggesting that correct initiation and termination had occurred. Accumulation of the transcript over a 24-h period indicated that it was relatively stable in vaccinia virus-infected cells. Since the pattern of transcription corresponded with the kinetics of p-gal protein synthesis, we concluded that template was either inaccessible to the T7 RNA polymerase or present at too low a copy number at early times after infection. Expression of HBsAg and HIV envelope proteins. To demonstrate the utility of the hybrid system, we expressed the DNA coding segments for HBsAg and HIV gpl60 following a procedure similar to that illustrated in Fig. 1 . The HBsAg coding sequence was isolated as a 1.3-kb BamHI fragment from pHBs4 (20) and inserted into the BamHI site of pTF7-3 (see Materials and Methods). A 2.5-kb EcoRV fragment containing the gp160 coding sequence was cleaved from mpPE-env and inserted into the BamHI site of pTF7-3 made blunt with Klenow polymerase. Recombinant plasmids containing HBsAg and HIV gpl60 coding sequences juxtaposed by T7 promoter (410) and termination (TO) sequences and flanked by vaccinia virus tk DNA sequences were isolated and recombined into the vaccinia virus genome by homologous recombination. TK-recombinant viruses vTF7HB-1 and vPE-5, which contained the HBsAg and gpl60 coding sequences, respectively, were isolated and purified.
Under conditions established for the synthesis of 3-gal, cells were coinfected with recombinant viruses vTF7-3 and vTF7HB-1 and harvested at various times after infection, and the levels of HBsAg in cell extracts and culture medium were quantitated by radioimmunoassay (AUSRIA II; Abbott Laboratories). Approximately 4 ,ug of HBsAg per 3 x 106 cells was detected by 48 h after infection (Table 5) . HBsAg synthesis was not detected in either cell extract or culture medium until 6 h after infection. This delay coincided with the kinetics of 3-gal synthesis shown previously and the requirement for replication of the template.
HBsAg consists of a major protein of apparent molecular weight 22,000 to 25,000 (P1) and a higher-molecular-weight glycoprotein (P2) (14) . As seen in Fig. 5A , two polypeptides with estimated molecular weights of 22,000 and 27,000, corresponding to P1 and P2, respectively, were present in lysates of cells coinfected with vTF7-3 and vTF7HB-1. The time course of synthesis of the HBsAg polypeptides by immunoblot analysis parralleled the radioimmunoassay results for the detection of the 22-nm particles (Table 5) .
Northern blot analysis of steady-state bulk RNA extracted from cells at various times after coinfection with vTF7-3 and vTF7HB-1 is shown in Fig. SB . A discrete 1.4-kb HBsAgspecific transcript was detected 6 h after infection and 1 3 6 12 24 1  <1  <1  3  <1  <1  6  13  <1  12  288  50  24  1,188  625  48 1,720 2,250 a CV-1 cell monolayers were coinfected with vaccinia virus recombinants vTF7-3 and vTF7HB-1 at 10 PFU/cell per virus. At 2 h, the virus inoculum was replaced with 2.5 ml of Eagle medium containing 2.5% FBS. At the indicated times after infection, cells were collected and separated from culture medium by centrifugation. Cell pellets were suspended in 2.5 ml of medium with 2.5% FBS, freeze-thawed three times, and sonicated. Equal portions of cell extracts and culture medium were tested for HBsAg by radioimmunoassay.
accumulated over a 24-h period. The onset of stable accumulation of HBsAg RNA and protein synthesis paralleled each other, as found with ,3-gal.
We also compared HIV envelope protein synthesis by the hybrid vaccinia virus-T7 system with that of a conventional vaccinia virus recombinant. The vaccinia virus recombinant, vPE-7, contained the same gp160 coding sequence described above placed downstream of the vaccinia virus P7.5 promoter. Synthesis of HIV env proteins was demonstrated by polyacrylamide gel electrophoresis of lysates of cells infected with the straight vaccinia virus recombinant vPE-7 or coinfected with vTF7-3 and vPE-5, blotting to nitrocellulose, and immunoprobing with serum from a patient with acquired immunodeficiency syndrome (AIDS). Several cell types were used in this analysis, BSC41, CV-1, and H9 lymphocytes. Immunoblot analyses of extracts from infected H9 and CV-1 cells are shown in Fig. 6 . A major band comigrating with authentic gpl60 precursor and additional ones corresponding to gpl20 and gp4l cleavage polypeptides were observed. Densitometry of the bands corresponding to gpl60 indicated a relative intensity ratio of 7.5:1 for the hybrid vaccinia virus-T7 and straight vaccinia virus expression systems, respectively. The amount of gpl6O-cross-reactive 24-h indicated that the RNA was fairly stable. This is an intriguing result, since previous studies have suggested that in vaccinia virus-infected cells, both cellular and viral mRNAs have very short half-lives (13, 17, 18) . It is our intention to further characterize the T7 transcripts, with particular regard to the ,cribed a simple and structure of their 5' and 3' ends. nialian cells by using
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